A kind of vascular stent and preparation method thereof
A vascular stent and element technology, applied in the medical field, can solve problems such as secondary damage to blood vessels, and achieve high accuracy.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] In the embodiment of the present invention, copper chloride (CuCl 2 ) as the source of divalent copper element, polylactic acid-glycolic acid copolymer (PLGA) is used as an auxiliary material, and the molar ratio of copper chloride and polylactic acid-glycolic acid copolymer is 9:1, wherein the content of divalent copper element material The amount is 1.7 μmol, mix copper chloride and polylactic acid-glycolic acid copolymer and spray on the base of the stent, and then place the stent in 80ml of normal human plasma sample solution to determine the concentration of divalent copper ions, divalent The concentration of copper ions as figure 1 shown.
Embodiment 2
[0026] In the embodiment of the present invention, citric acid chelated copper is used as the source of divalent copper element, poly-DTH iminocarbonic acid, polyethylene terephthalate and poly-β-hydroxybutyrate are used as auxiliary materials, and citric acid chelated The ratio of the amount of copper substance to the sum of the amount of three auxiliary materials of poly DTH iminocarbonic acid, polyethylene terephthalate and poly β-hydroxybutyrate is 9:1, wherein, divalent copper element The amount of the substance is 1.9 μmol. After mixing copper citrate chelate with poly-DTH iminocarbonic acid, polyethylene terephthalate and poly-β-hydroxybutyrate, it is modified on the base of the vascular stent, and then the vascular stent Placed in 80ml of normal human plasma sample solution to determine the concentration of divalent copper ions, the concentration of divalent copper ions is as follows figure 2 shown.
Embodiment 3
[0028] In the embodiment of the present invention, copper chloride (CuCl 2 ) as a divalent copper element source, adopting polyfumaric acid as an auxiliary material, the amount ratio of cupric chloride and polyfumaric acid substance is 19:1, wherein, the amount of divalent copper element substance is 1.4 μ mol, and cupric chloride After mixing with polyfumaric acid, it is electroplated on the base of the vascular stent, and then the vascular stent is placed in 80ml of normal human plasma sample solution to measure the concentration of divalent copper ions. The concentration of divalent copper ions is as follows: image 3 shown.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


